BeyondSpring Inc. Current Income Tax Expense (Benefit)
BeyondSpring Inc. (BYSI) reported Current Income Tax Expense (Benefit) of -$90.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-03-25
- BeyondSpring Inc. current income tax expense (benefit) for the quarter ending 2018-03-31 was $0.00.
- BeyondSpring Inc. current income tax expense (benefit) for the quarter ending 2017-12-31 was $0.00.
- BeyondSpring Inc. current income tax expense (benefit) for the quarter ending 2017-09-30 was $0.00.
- BeyondSpring Inc. current income tax expense (benefit) for the quarter ending 2017-06-30 was $0.00.
- BeyondSpring Inc. current income tax expense (benefit) for fiscal 2025 was -$90.00K.
- BeyondSpring Inc. current income tax expense (benefit) for fiscal 2024 was -$96.00K.
- BeyondSpring Inc. current income tax expense (benefit) for fiscal 2023 was -$92.00K.
| Period end | Current Income Tax Expense (Benefit) 3 month | Current Income Tax Expense (Benefit) 6 month | Current Income Tax Expense (Benefit) 9 month | Current Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$90.00K 10-K · filed 2026-03-25 | |||
| 2024-12-31 | -$96.00K 10-K · filed 2026-03-25 | |||
| 2023-12-31 | -$92.00K 10-K · filed 2025-03-27 | |||
| 2022-12-31 | $163.00K 20-F · filed 2023-04-18 | |||
| 2021-12-31 | $3.57M 20-F · filed 2023-04-18 | |||
| 2020-12-31 | $0.00 20-F · filed 2023-04-18 | |||
| 2019-12-31 | $0.00 20-F · filed 2022-04-14 | |||
| 2018-03-31 | $0.00 6-K · filed 2018-06-21 | $0.00 derived: sum of 2 quarters · filed 2018-06-21 | $0.00 derived: sum of 3 quarters · filed 2018-06-21 | $0.00 derived: sum of 4 quarters · filed 2018-06-21 |
| 2017-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2018-04-03 | $0.00 derived: sum of 2 quarters · filed 2018-04-03 | $0.00 derived: sum of 3 quarters · filed 2018-04-03 | $0.00 20-F · filed 2018-04-03 |
| 2017-09-30 | $0.00 6-K · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 6-K · filed 2017-11-09 | $0.00 derived: sum of 4 quarters · filed 2018-06-21 |
| 2017-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2017-08-21 | $0.00 6-K · filed 2017-08-21 | $0.00 derived: sum of 3 quarters · filed 2018-06-21 | $0.00 derived: sum of 4 quarters · filed 2018-06-21 |
| 2017-03-31 | $0.00 6-K · filed 2018-06-21 | $0.00 derived: sum of 2 quarters · filed 2018-06-21 | $0.00 derived: sum of 3 quarters · filed 2018-06-21 | $0.00 derived: sum of 4 quarters · filed 2018-06-21 |
| 2016-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2018-04-03 | $0.00 derived: sum of 2 quarters · filed 2018-04-03 | $0.00 derived: sum of 3 quarters · filed 2018-04-03 | $0.00 20-F · filed 2018-04-03 |
| 2016-09-30 | $0.00 6-K · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 6-K · filed 2017-11-09 | |
| 2016-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2017-08-21 | $0.00 6-K · filed 2017-08-21 | ||
| 2016-03-31 | $0.00 6-K · filed 2017-05-22 | |||
| 2015-12-31 | $0.00 20-F · filed 2018-04-03 | |||
| 2014-12-31 | $0.00 20-F · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |